Aptus Clinical is a clinical CRO provider formed by three former AstraZeneca colleagues who have over 75 years’ combined drug development experience. Our mission is to be the partner of choice for biopharmaceutical companies and academic researchers, supporting them in their quest to develop new and valued medicines. We understand the challenges faced by our clients and will provide key insight and experience to meet the needs of our customers by delivering operational excellence in order to achieve the exacting standards of the industry With experience ranging from early methodology studies and first time in man, through proof of concept to Phase III registration and clinical pharmacology studies this breadth and depth of knowledge is at the disposal of our customers. We recognise that the increasing legislative, regulatory, ethical and patient focused expectations being placed on the conduct of clinical studies, is making their successful conduct and delivery ever more costly and difficult to achieve. With this in mind, Aptus Clinical is continually developing a team of highly experienced clinical research experts who have extensive insight into the effective delivery of studies and are passionate about partnering with biotechs, pharma and academia to provide bespoke clinical delivery solutions. Whether you are a company or academic institution looking for strategic input to study designs or need access to flexible, cost effective and experienced clinical research resources to deliver high quality studies, then please get in touch.